Related Experiment Video
Updated: May 29, 2026

07:30
Robot-Assisted Kidney Transplantation
Published on: July 19, 2021
Selective renal parenchymal clamping in robot-assisted laparoscopic partial nephrectomy: a multi-institutional
Davis P Viprakasit1, Ithaar Derweesh, Carson Wong
1Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, Tennessee 37232, USA.
Journal of Endourology
|September 10, 2011
Summary
Robot-assisted laparoscopic partial nephrectomy (RALPN) using a novel clamp for regional ischemia is feasible, achieving hemostasis without hilar occlusion. Careful patient selection is crucial for optimal outcomes in this preliminary study.
Area of Science:
- Urology
- Minimally Invasive Surgery
- Oncology
Background:
- Robot-assisted laparoscopic partial nephrectomy (RALPN) is a standard treatment for renal tumors.
- Achieving hemostasis without compromising renal function remains a challenge.
- Selective renal ischemia techniques aim to minimize warm ischemia time and preserve kidney function.
Purpose of the Study:
- To evaluate the multi-institutional feasibility and outcomes of using a laparoscopic clamp for selective regional ischemia during RALPN.
- To assess the safety and efficacy of inducing regional ischemia without complete hilar occlusion.
Main Methods:
- Retrospective review of patients undergoing RALPN with selective regional clamping at four institutions.
- Analysis of operative times, clamping duration, complications, and oncological outcomes.
- Assessment of renal function using glomerular filtration rate (GFR) preoperatively and postoperatively.
Main Results:
- RALPN with parenchymal clamping was successful in 85% of 20 patients.
- Median operative time was 190 minutes, with a selective clamp time of 26 minutes.
- No significant difference in preoperative and postoperative GFR was observed. Renal cell carcinoma was confirmed in 71% of cases with no positive margins.
Conclusions:
- Selective regional ischemia using a laparoscopic parenchymal clamp is a feasible technique for hemostasis during RALPN.
- Careful preoperative patient and tumor selection is essential for successful application.
- Further comparative studies are warranted to establish the definitive utility of this approach.

